Sai Life Science, a TPG-backed CRDMO, files DRHP with SEBI for IPO, aiming to raise Rs 800 crore.
Sai Life Science, a TPG-backed CRDMO, has filed a DRHP with SEBI for its IPO, aiming to raise Rs 800 crore through a fresh issue and an offer-for-sale. The IPO proceeds will be used for debt repayment and general corporate purposes. The company, which offers comprehensive drug discovery, development, and manufacturing services, has served over 280 innovator pharmaceutical companies in FY24.
July 15, 2024
4 Articles